Evidence map›Paper›PMID 32909113›Full record

ArticleBiological trace element research2021

Safety Assessments of Nickel Boride Nanoparticles on the Human Pulmonary Alveolar Cells by Using Cell Viability and Gene Expression Analyses.

Hasan Türkez, Mehmet Enes Arslan, Erdal Sönmez, Abdulgani Tatar, Fatime Geyikoğlu, Metin Açikyildiz, Adil Mardinoğlu

Abstract read
PubMed Publisher
In one paragraph

Article in Biological trace element research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Hasan TürkezDepartment of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
Mehmet Enes ArslanDepartment of Molecular Biology and Genetics, Faculty of Science, Erzurum Technical University, Erzurum, Turkey. enes.aslan@erzurum.edu.tr.ORCID http://orcid.org/0000-0002-1600-2305
Erdal SönmezAdvanced Materials Research Laboratory, Department of Nanoscience & Nanoengineering, Graduate School of Natural and Applied Sciences, Ataturk University, Erzurum, Turkey.
Abdulgani TatarDepartment of Medical Genetics, Medical Faculty, Atatürk University, Erzurum, Turkey.
Fatime GeyikoğluDepartment of Biology, Faculty of Arts and Sciences, Atatürk University, Erzurum, Turkey.
Metin AçikyildizDepartment of Chemistry, Faculty of Science and Art, Kilis 7 Aralık University, Kilis, Turkey.
Adil MardinoğluCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, SE1 9RT, UK.
Atatürk University · TRErzurum Technical University · TRKilis 7 Aralık University · TRKing's College London · GB

Funding

National Boron Research Institute (BOREN) supported this research Grant No: Ç0391.
6 · The paper itself

Abstract

Nickel boride is generally used in the steel industry as a melting accelerator due to its feature of creating a protective and stable attribute at high temperatures. It is also used to improve the hardenability of the steel with boron addition in the production. Thus, safety studies and biocompatibility analysis of nickel boride should be performed comprehensively to understand the limitations of use in various areas. In the present study, nickel boride nanoparticles (Ni

Indexed as

Metal NanoparticlesNanoparticlesAlveolar Epithelial CellsBoranesCell SurvivalGene ExpressionHumansNickelX-Ray DiffractionBoranesNickelnickel borideHuman pulmonary alveolar epithelial cellsIn vitro, gene expressionNickel boride nanoparticlesPathway analysis

Identifiers

PMID32909113
OpenAlexW3084443024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.